Abstract
This paper review the most important aspects of carrier detection procedures, genetic counselling, population screening and prenatal diagnosis of β-thalassemias. Carrier detection can be made retrospectively, following the birth of an affected child or prospectively. Several programmes, with the aim of preventing homozygous β-thalassemia, based on carrier screening and counselling of couples at marriage; preconception or early pregnancy, are operating in several Mediterranean at-risk populations. These programmes have been very effective, as indicated by increasing knowledge on thalassemia and its prevention by the target population and by the marked decline of the incidence of thalassemia major. Carrier detection is carrierd out by haematological methods followed by mutation detection by DNA analysis. Prenatal diagnosis is accomplished by mutation analysis on PCR-amplified DNA from chorionic villi. Future prospects include automation of the process of mutation-detection, simplification of preconception and preimplantation diagnosis and fetal diagnosis by analysis of fetal cells in maternal circulation.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Angastiniotis M, Modell B, Boulinzhenkov V. Prevention and control of haemoglobinopathies.Bul WHO. 1995;73:375–386.
Weatherall DJ, Clegg JB. The Thalassemia Syndromes. Ed 4. Blackwell Scientific Publication, Oxford, 2001.
WHO Scientific Group: Control of hereditary diseases. WHO Technical Report Series 865, 1996.
Galanello R, Ruggeri R, Addis M, Paglietti E, Cao A. Hemoglobin A2 in iron deficiency β-thalassemia heterozygotes.Hemoglobin. 1981;5:613–618.
Melis MA, Pirastu M, Galanello R, et al. Phenotypic effect of heterozygous α and β0-thalassemia interaction.Blood. 1983; 62:226–229.
Rosatelli C, Falchi AM, Scalas MT, et al. Hematological phenotype of the double heterozygous state for α and β-thalassemia.Hemoglobin. 1984;8:25–35.
Galanello R, Barella 5, Ideo A, et al. Genotype of subjects with borderline Hb A2: Implication for β-thalassemia carrier screening.Am J Hemat. 1994;46:79–81.
Gonzales-Redondo JM, Stoming TA, Kutlar A, et al. A C-rT substitution at nt-iOl in a conserved DNA sequence of the promoter region of the β-globin gene is associated with “silent” β-thalassemia.Blood. 1989;73:1705–1711.
Galanello R, Ruggeri R, Paglietti E, et al. A family with segregating triplicated u-globin loci and β-thalassemia.Blood. 1983;62:1035–1040.
Thein SL. 51-Hakim I and Hoffbrand AB Thalassemia intermedia: a new molecular basis.Br J Haemat. 1984;56:333–337.
Kulozik AE, Thein SL, Wainscoat 15, et al. Thalassemia intermedia: interaction of the triple α-globin gene arrangement and heterozygous β-thalassemia.Br J Haemat. 1987;66:109–112.
Cao A, Rosatelli C. Screening and prenatal diagnosis of the haemoglobinopathies. In: Higgs DR & Weatherall DJ, eds.Bailliere’s Clinical Haematology. The Haemoglobinopathies 1993;6:263–286.
Galanello R, Barella S, Gasperini D, et al. Evaluation of a new automatic HPLC analyzer for thalassemia and hemoglobin variants screening.J Autom Chem. 1995;17:73–76.
Cao A, Galanello R, Rosatelli MC. Prenatal diagnosis and screening of the haemoglobinopathies. In: Bailliere’s Clinical Haematology. International Practice and Research: The Haemoglobinopathies (eds Higg D.R. & Weatherall D.J.) p. 215–238 (Bailliere Tindall, London, 1998).
Cao A. 1993 William Allan Award Address.Am J Hum Genet. 1994;54:397–402.
Cao A, Saba L, Galanello R, Rosatelli MC. Molecular diagnosis and carrier screening for β-thalassemia.JAMA. 1997; 278:1273–1277.
Loukopoulos D. Current status of thalassemia and the sickle cell syndromes in Greece.Sem Haematol. 1996;33:76–86.
Cao A, Cossu P, Monni G, Rosatelli C. Chorionic villus sampling and acceptance rate of prenatal diagnosis.Pren Diagn. 1987;7:531–533.
Old JM. DNA-Based Diagnosis of the Hemoglobin disorders. In Steinberg MH, Forget BG, Higgs DR, Nagel RL. (eds): Disorders of Hemoglobin. Genetics, Pathophusiology, and Clinical Management. Cambridge University Press 2001, pp 941–957.
Newton CR, Graham A, Hepteinstall LE, et al. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS).Nucleic Acid Res. 1989;17:2503–2516.
Saiki RK, Walsh PS, Levenson CH, Erlich HA. Genetic analysis of amplified DNA with immobilized sequence-specific oligonucleotide probes.Proc Natl Acad Sci USA. 1989;86: 6230.
Cai 5P, Kan YW. Identification of the multiple β-thalassemia mutations by denaturing gradient gel electrophoresis.J Clin Invest. 1990;85:550–553.
Rosatelli MC, Dozy A, Faa V, et al. Molecular characterisation of β-thalassemia in the Sardinian population.Am J Hu Genet. 1992;50:50:422-426.
Rosatelli C, Tuveri T, Scalas MT, et al. Molecular screening and fatal diagnosis of β-thalassemia in the Italian population.Hum Genet. 1992;89:585–589.
Murru S, Loudianos G, Porcu 5, et al. A P-thalassemia phenotype not linked to the P-globin cluster in an italian family.Br J Haemat. 1992;81:283–287.
Underhill PA, Jin L, Lin AA, et al. Detection of numerous Y chromosome biallelic polymorphisms by denaturing high-performance liquid chromatography.Genome Res. 1997;7:947–949.
Yershov G, Barsky V, Belgovskly A, et al. DNA analysis and diagnostics on oligonucleotide microchips.Proc Natl Acad Sci USA. 1996;93:4913–4918.
Huisman TH, Carver MF. The β- and 5-thalassemia repository (Ninth Edition).Hemoglobin. 1998;22:169–195.
Moi P, Paglietti E, Sanna A, et al. Delineation of the molecular basis of δ and normal HbA2 β-thalassemia.Blood. 1988;72:530–533.
Tzetis M, Traeger-Synodinos J, Kanavakis E, Metaxotou-Mavromati A, Kattamis C. The molecular basis of normal HbA2 (type 2) β-thalassemia in Greece.Hematol Pathol. 1994;8: 25–34.
Galanello R, Melis MA, Podda A, et al. Deletion S-thalassemia; the 7.2 kb deletion of Corf δβ-thalassemia in a non-β-thalassaemic chromosome [letter].Blood. 1990;75:1447–1449.
Loudianos G, Cao A, Pirastu M, Vassilopoulos G, Kollia p, Loukopoulos D. Molecular basis of the β-thalassemia in cis to hemoglobin Knossos variant.Blood. 1991;77:2087–2088.
Olds RJ, Sura T, Jackson B, et al. A novel βo mutation in cis with Hb Knossos: A study of different genetic interactions in three Egyptian families.Br J Haematol. 1991;78:430.
Pirastu M, Ristaldi MS, Loudianos G, et al. Molecular analysis of atypical β-thalassemia heterozygotes.Ann N Y Acad Sci. 1990;612:90–97.
Miggs DR, Bowden DK. Clinical and Laboratory features of the α-thalassemia syndromes In Steinberg MH, Forget BG, Higgs DR, Nagel RL. (eds): Disorders of Hemoglobin Genetics, Pathophysiology, and Clinical Management. Cambridge University Press 2001, pp 431–469.
Kattamis AC, Camaschella C, Sivera P, Surrey S, Fortina P. Human α-thalassemia syndromes: detection of molecular defects.Am J Hematol. 1996;53:81–91.
Wainscoat JS, Them SL, Weatherall DJ. Thalassemia intermedia.Blood Reviews. 1987;1:273–279.
Weatherall DJ. Phenotype/genotype relationships in monogenic disease: lessons from the thalassemias.Nat Rev Genetics. 2001; 2:245–255.
Cao A. 1993 William Allan Award Address.Am J Hum Genet. 1994;54:397–402.
Galanello R, Dessi E, Melis MA, et al. Molecular analysis of βo-thalassemia intermedia in Sardinia.Blood. 1989;74:823–827.
Kan YW, Nathan DG. Mild thalassemia: the result of interactions of α and β-thalassemia genes.J Clin Invest. 1970;49: 635–642.
Chang YC, Smith KD, Moore RD, Serjeant GR, Dover GJ. An analysis of fetal hemoglobin variation in sickle cell disease: the relative contribution of the X-linked factor, β-globin haplotypes, α-globin gene number, gender and age.Blood. 1995;85:1111–1117.
Dover G, Smith KD, Chang YC, et al. Fetal hemoglobin levels in sickle cell disease and normal individuals are partially controlled by an X-linked gene located at Xp22.2.Blood. 1992;80:816–824.
Stamatoyannopoulos G, Grosveld F. Hemoglobin Switching. In Stamatoyannopoulos G, Majerus PW, Perlmutter RM, Varmus H (eds). The Molecular Basis of Blood Diseases, ed. 3. W.B. Saunders Company, 2001, pp 135–182.
Galanello R, Ruggeri R, Paglietti E, Addis M, Melis MA, Cao A. A family with segregating triplicated α-globin loci and-thalassemia.Blood. 1983;62:1035–1040.
Kanavakis E, Metaxotou-Mavromati A, Kattamis C, Wainscoat JS, Wood WG. The triplicated α gene locus and β-thalassemia.Br J Haematol. 1983;54:201–207.
Kulozik AE, Them SL, Wainscoat JS, et al. Thalassemia intermedia: interaction of the triple α-globin gene arrangement and heterozygous β-thalassemia.Br I Haematol. 1987; 66:109–112.
Them SL, Hesketh C, Taylor P, et al. Molecular basis for dominantly inherited inclusion body β-thalassemia.Proc Natl Acad Sci USA. 1990;87:3924–3928.
Kan YW, Golbus MS, Klein P, Dozy AM. Successful application of prenatal diagnosis in a pregnancy at risk for homozygous β-thalassemia.N E J Med. 1975;292:1096–1099
Kan YW, Lee KY, Furbetta M, Angius A, Cao h. Polymorphism of DNA sequence in the β-globin gene region: application to prenatal diagnosis of β-thalassemia in sardinia.N E J Med. 1980;302:185–188.
Pirastu M, Kan YW, Cao A, Conner BJ, Teplitz RI, Wallace RB. Prenatal diagnosis of β-thalassemia. Detection of a single nucleotide mutation in DNA.N E J Med. 1983;309:284–287.
Monni G, Ibba RM, Olla G, Rosatelli C, Cao A. Chorionic villus sampling by rigid forceps: experience with 300 cases at risk for thalassemia major.Am J Obstet Gynecol. 1987;156: 912–914.
Monni G, Ibba RM, Olla G, Rosatelli C, Cao A. Prenatal diagnosis of β-thalassemia by second trimester chorionic villus sampling.Pren Diagn. 1988;8:447–451.
Monni G, Ibba RM, Lai R, et al. Early transabdominal chorionic villus sampling for couplet at high genetic risk.Am J Obstet Gynecol. 1993;168:170–173.
Monni G, Olla G, Cao A. Patient’s choice between transcervical and transabdominal chorionic villus sampling.Lancet. 1988;i:1057.
Rosatelli MC, Dozy A, Faa V, et al. Molecular characterisation of β-thalassemia in the Sardinian population.Am J Hum Genet. 1992;50:422–426.
Handyside AM, Lesko JG, Tarin JJ, et al. Birth of a normal girl after in vitro fertilization and preimplantation diagnostic testing for cystic fibrosis.N Engl J Med. 1992;327:905–909.
Monni G, Lai R, Cau G, et al. Acceptability of preimplantation diagnosis. In From Gametes To Embryos.Pren Diagn. 1992;12S:S24.
Bianchi DW, Flint AF, Pizzimenti MF, Knoll JH, Latt SA Isolation of fetal DNA from nucleated erythrocytes in maternal blood.Proc Natl Acad Sci. (USA) 1990;87:3279–3283.
Cheung M-C, Goldberg JD, Kan YW. Prenatal diagnosis of sickle cell anemia and thalassemia by analysis of fetal cells in maternal blood.Nat Genet. 1996;14:264–268.
Author information
Authors and Affiliations
About this article
Cite this article
Cao, A. Carrier screening and genetic counselling in β-thalassemia. Int J Hematol 76 (Suppl 2), 105–113 (2002). https://doi.org/10.1007/BF03165098
Issue Date:
DOI: https://doi.org/10.1007/BF03165098